SCHEMBL9512392

SCHEMBL9512392

CCCC[C@H]1CC[C@H](c2ccc(C#Cc3ccc(OC)c(F)c3F)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
AR P10275 1/20 0.31
ESR2 Q92731 1/20 0.31
ACACB O00763 2/20 0.31
PAX8 Q06710 1/20 0.31
ACHE P22303 1/20 0.31
HTR4 Q13639 1/20 0.31
SPHK1 Q9NYA1 1/20 0.30
DRD2 P14416 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510192 0.97 CYP2C9 (0.34) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9509344 0.96 SPHK1 (0.34) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9511371 0.96 SPHK1 (0.34) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9509449 0.93 CYP2C9 (0.41) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9510166 0.91 CYP2C9 (0.34) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9512502 0.90 RAB9A (0.35) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9510141 0.89 ACACB (0.33) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL9511457 0.89 CYP2C9 (0.33) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL10513662 0.89 CYP2C9 (0.32) CYP2C9ALDH1A1MAPTLMNAMEN1
SCHEMBL23618045 0.89 ACACB (0.33) ARACACBPAX8DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0308438-B1 LIQUID CRYSTAL PHASE CONTAINING TOLANES MERCK PATENT GmbH (DE) 1993-09-29 EP disclosed